UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.51 Million Stock Holdings in ProAssurance Co. (NYSE:PRA)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of ProAssurance Co. (NYSE:PRA - Free Report) by 10.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 157,977 shares of the insurance provider's stock after purchasing an additional 15,542 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.31% of ProAssurance worth $2,513,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in PRA. Wealthfront Advisers LLC bought a new stake in shares of ProAssurance in the fourth quarter valued at approximately $359,000. Deutsche Bank AG raised its stake in ProAssurance by 50.1% during the fourth quarter. Deutsche Bank AG now owns 47,679 shares of the insurance provider's stock worth $759,000 after acquiring an additional 15,921 shares in the last quarter. Amundi increased its stake in shares of ProAssurance by 182.3% in the fourth quarter. Amundi now owns 25,634 shares of the insurance provider's stock valued at $389,000 after buying an additional 16,552 shares in the last quarter. Northern Trust Corp increased its stake in shares of ProAssurance by 3.1% in the fourth quarter. Northern Trust Corp now owns 559,694 shares of the insurance provider's stock valued at $8,905,000 after buying an additional 16,983 shares in the last quarter. Finally, Prudential Financial Inc. boosted its holdings in ProAssurance by 57.3% in the fourth quarter. Prudential Financial Inc. now owns 86,703 shares of the insurance provider's stock valued at $1,379,000 after acquiring an additional 31,580 shares during the last quarter. Institutional investors own 85.58% of the company's stock.

ProAssurance Price Performance

Shares of NYSE:PRA traded down $0.03 during trading on Friday, reaching $23.14. 456,400 shares of the company traded hands, compared to its average volume of 461,205. The company's 50 day moving average is $23.13 and its two-hundred day moving average is $18.67. The firm has a market capitalization of $1.19 billion, a PE ratio of 27.87 and a beta of 0.14. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.35. ProAssurance Co. has a 52 week low of $10.76 and a 52 week high of $23.70.

ProAssurance (NYSE:PRA - Get Free Report) last released its earnings results on Tuesday, May 6th. The insurance provider reported $0.13 earnings per share for the quarter, missing analysts' consensus estimates of $0.19 by ($0.06). ProAssurance had a net margin of 3.71% and a return on equity of 2.65%. The company had revenue of $236.28 million for the quarter, compared to the consensus estimate of $272.85 million. During the same quarter in the previous year, the company posted $0.08 earnings per share. The business's revenue was down 4.5% compared to the same quarter last year. As a group, sell-side analysts predict that ProAssurance Co. will post 0.8 earnings per share for the current year.

Analyst Upgrades and Downgrades

PRA has been the topic of a number of recent analyst reports. Piper Sandler raised their target price on ProAssurance from $18.00 to $25.00 and gave the stock a "neutral" rating in a report on Thursday, May 8th. Wall Street Zen initiated coverage on ProAssurance in a research report on Monday, May 19th. They issued a "hold" rating on the stock. Citizens Jmp lowered ProAssurance from an "outperform" rating to a "market perform" rating in a research report on Thursday, April 3rd. Raymond James downgraded ProAssurance from a "market perform" rating to an "underperform" rating in a research note on Thursday, April 10th. Finally, Citigroup downgraded ProAssurance to a "market perform" rating in a research note on Thursday, April 3rd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat, ProAssurance has an average rating of "Hold" and an average target price of $21.00.

About ProAssurance

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.